Correlation Between Telomir Pharmaceuticals, and Teva Pharma

Can any of the company-specific risk be diversified away by investing in both Telomir Pharmaceuticals, and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telomir Pharmaceuticals, and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telomir Pharmaceuticals, Common and Teva Pharma Industries, you can compare the effects of market volatilities on Telomir Pharmaceuticals, and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telomir Pharmaceuticals, with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telomir Pharmaceuticals, and Teva Pharma.

Diversification Opportunities for Telomir Pharmaceuticals, and Teva Pharma

0.18

Correlation Coefficient

Telomir Pharmaceuticals,  Teva Pharma

Average diversification

The 3 months correlation between Telomir and Teva is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Telomir Pharmaceuticals, Commo and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Telomir Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telomir Pharmaceuticals, Common are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Telomir Pharmaceuticals, i.e., Telomir Pharmaceuticals, and Teva Pharma go up and down completely randomly.

Pair Corralation between Telomir Pharmaceuticals, and Teva Pharma

Given the investment horizon of 90 days Telomir Pharmaceuticals, Common is expected to generate 4.05 times more return on investment than Teva Pharma. However, Telomir Pharmaceuticals, is 4.05 times more volatile than Teva Pharma Industries. It trades about 0.03 of its potential returns per unit of risk. Teva Pharma Industries is currently generating about 0.08 per unit of risk. If you would invest  700.00  in Telomir Pharmaceuticals, Common on September 19, 2024 and sell it today you would lose (233.00) from holding Telomir Pharmaceuticals, Common or give up 33.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	44.15%
Values	Daily Returns

Telomir Pharmaceuticals, Commo  vs.  Teva Pharma Industries

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Teva Pharma Industries

Risk-Adjusted Performance

6 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Teva Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telomir Pharmaceuticals, and Teva Pharma

The main advantage of trading using opposite Telomir Pharmaceuticals, and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telomir Pharmaceuticals, position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.

The idea behind Telomir Pharmaceuticals, Common and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.